Enforcement Report - Week of November 1, 2023
Enforcement Report - Week of August 19, 2020
Enforcement Report - Week of June 3, 2020
West-Ward Pharms Int`s Generic Febuxostat Receives Approval in US
The Federal Circuit exhibited the current status of its obviousness jurisprudence in affirming the District Court's determination that the asserted claims of U.S. Patent No. 8,410,131 were not obvious in a decision handed down this week in Novartis Pharmaceuticals Corp. v. West-Ward Pharmaceuticals Int'l.
West-Ward Pharms Int`s Generic Tetrabenazine Receives Approval in US
West-Ward Pharms's Generic Rufinamide Receives Tentative Approval in US
West-Ward Pharms' Generic Dalfampridine Receives Approval in US
West-Ward Pharm's Generic Clobazam Receives Approval in US
West-Ward Pharms' Generic Clobazam Receives Approval in US